Free Trial

ARS Pharmaceuticals (SPRY) Short Interest Ratio & Short Volume

ARS Pharmaceuticals logo
$15.26
+0.54 (+3.67%)
(As of 11/1/2024 ET)

ARS Pharmaceuticals Short Interest Data

ARS Pharmaceuticals (SPRY) has a short interest of 11.92 million shares, representing 24.22% of the float (the number of shares available for trading by the public). This marks a 7.39% increase in short interest from the previous month. The short interest ratio (days to cover) is 10.5, indicating that it would take 10.5 days of the average trading volume of 841,843 shares to cover all short positions.

Current Short Interest
11,920,000 shares
Previous Short Interest
11,100,000 shares
Change Vs. Previous Month
+7.39%
Dollar Volume Sold Short
$181.54 million
Short Interest Ratio
10.5 Days to Cover
Last Record Date
October 15, 2024
Outstanding Shares
96,940,000 shares
Float Size
49,210,000 shares
Short Percent of Float
24.22%
Today's Trading Volume
1,069,108 shares
Average Trading Volume
841,843 shares
Today's Volume Vs. Average
127%
Short Selling ARS Pharmaceuticals?
cover of A Guide to High-Short-Interest Stocks and How to Trade Them ebook

Sign up to receive the latest short interest report for ARS Pharmaceuticals and its competitors with MarketBeat's FREE newsletter.

Skip Charts & View Short Interest History

SPRY Short Interest Over Time

SPRY Days to Cover Over Time

SPRY Percentage of Float Shorted Over Time

ARS Pharmaceuticals Short Interest History

Report DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date
10/15/202411,920,000 shares $181.54 million +7.4%24.2%10.5 $15.23
9/30/202411,100,000 shares $160.95 million -4.6%22.7%10.1 $14.50
9/15/202411,640,000 shares $154.81 million +6.2%23.8%10.4 $13.30
8/31/202410,960,000 shares $142.26 million -9.2%22.5%10.5 $12.98
8/15/202412,070,000 shares $163.43 million +21.6%25.3%12.9 $13.54
7/31/20249,930,000 shares $107.94 million +13.6%20.9%15.7 $10.87
7/15/20248,740,000 shares $101.91 million +27.0%18.4%15.3 $11.66
6/30/20246,880,000 shares $58.55 million +0.4%14.5%12.5 $8.51
6/15/20246,850,000 shares $59.32 million +0.4%14.5%12.7 $8.66
5/31/20246,820,000 shares $60.56 million -0.7%15.0%11.5 $8.88
5/15/20246,870,000 shares $61.01 million +7.7%16.1%10.1 $8.88
4/30/20246,380,000 shares $55.51 million +4.8%15.8%9 $8.70
4/15/20246,090,000 shares $56.27 million +10.7%14.4%9 $9.24
3/31/20245,500,000 shares $56.21 million +29.4%13.1%8.5 $10.22
3/15/20244,250,000 shares $38.93 million -7.8%10.2%7.3 $9.16
2/29/20244,610,000 shares $38.59 million -5.1%11.2%10 $8.37
2/15/20244,860,000 shares $35.28 million No Change11.8%11.3 $7.26
1/31/20244,860,000 shares $30.18 million -30.0%11.8%11.4 $6.21
1/15/20246,940,000 shares $41.02 million -0.4%16.9%13.8 $5.91
12/31/20236,970,000 shares $38.20 million +4.3%16.9%12.6 $5.48
12/15/20236,680,000 shares $34.80 million +10.8%16.2%9.3 $5.21
11/30/20236,030,000 shares $29.12 million +1.5%14.7%4.4 $4.83
11/15/20235,940,000 shares $26.91 million -10.0%14.6%4.3 $4.53
10/31/20236,600,000 shares $23.56 million +16.4%16.2%5 $3.57
10/15/20235,670,000 shares $21.15 million -3.4%14.0%4.6 $3.73
9/30/20235,870,000 shares $22.19 million +1.6%14.5%4.9 $3.78
9/15/20235,780,000 shares $41.96 million +7.6%14.2%5.1 $7.26
8/31/20235,370,000 shares $38.07 million -7.7%10.4%10.2 $7.09
8/15/20235,820,000 shares $40.97 million -4.1%12.2%9.7 $7.04
7/31/20236,070,000 shares $44.61 million -2.7%12.8%3.7 $7.35
7/15/20236,240,000 shares $42.62 million +5.2%13.1%3.8 $6.83
6/30/20235,930,000 shares $39.73 million +9.4%12.5%3.7 $6.70
6/15/20235,420,000 shares $32.79 million +22.4%11.4%3.4 $6.05
5/31/20234,430,000 shares $30.83 million +22.4%9.4%3 $6.96
5/15/20233,620,000 shares $28.27 million No Change7.7%2.7 $7.81

SPRY Short Interest - Frequently Asked Questions

What is ARS Pharmaceuticals' current short interest?

Short interest is the volume of ARS Pharmaceuticals shares that have been sold short but have not yet been covered or closed out. As of October 15th, traders have sold 11,920,000 shares of SPRY short. 24.22% of ARS Pharmaceuticals' shares are currently sold short. Learn More on ARS Pharmaceuticals' current short interest.

What is a good short interest ratio for ARS Pharmaceuticals?

The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. SPRY shares currently have a short interest ratio of 10.0. Learn More on ARS Pharmaceuticals's short interest ratio.

Which institutional investors are shorting ARS Pharmaceuticals?

As of the most recent reporting period, the following institutional investors, funds, and major shareholders have reported short positions of ARS Pharmaceuticals: Susquehanna International Group LLP. These positions are disclosed in Form 13F filings with the Securities and Exchange Commission.

What is a good short interest percentage for ARS Pharmaceuticals?

Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock. Companies with a short interest percentage of 20% or more indicates widespread negative sentiment. 24.22% of ARS Pharmaceuticals' floating shares are currently sold short.

Is ARS Pharmaceuticals' short interest increasing or decreasing?

ARS Pharmaceuticals saw a increase in short interest in the month of October. As of October 15th, there was short interest totaling 11,920,000 shares, an increase of 7.4% from the previous total of 11,100,000 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment.

What is ARS Pharmaceuticals' float size?

ARS Pharmaceuticals currently has issued a total of 96,940,000 shares. Some of ARS Pharmaceuticals' outstanding shares are available for trading, while others are subject to various restrictions. The public float, also referred to as floating shares or "the float", are shares that publicly owned, unrestricted and available to trade on the open market. ARS Pharmaceuticals currently has a public float of 49,210,000 shares.

How does ARS Pharmaceuticals' short interest compare to its competitors?

24.22% of ARS Pharmaceuticals' shares are currently sold short. Here is how the short interest of companies in the industry of "pharmaceutical products" compare to ARS Pharmaceuticals: Blueprint Medicines Co. (5.71%), Krystal Biotech, Inc. (12.32%), Avidity Biosciences, Inc. (13.55%), Arcellx, Inc. (10.33%), BridgeBio Pharma, Inc. (12.10%), Organon & Co. (4.88%), Biohaven Ltd. (9.87%), Crinetics Pharmaceuticals, Inc. (8.23%), Ultragenyx Pharmaceutical Inc. (3.43%), Immunovant, Inc. (20.84%),

Which stocks are the most shorted right now?

As of the most recent reporting period, the following stocks had the largest short interest positions: Charter Communications, Inc. ($4.14 billion), AppLovin Co. ($3.15 billion), Paychex, Inc. ($2.69 billion), Nu Holdings Ltd. ($2.48 billion), Cencora, Inc. ($2.24 billion), International Paper ($2.04 billion), Tractor Supply ($1.96 billion), Coinbase Global, Inc. ($1.93 billion), Moderna, Inc. ($1.91 billion), and SoFi Technologies, Inc. ($1.84 billion). View all of the most shorted stocks.

What does it mean to sell short ARS Pharmaceuticals stock?

Short selling SPRY is an investing strategy that aims to generate trading profit from ARS Pharmaceuticals as its price is falling. SPRY shares are trading up $0.54 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit.

How does a short squeeze work against ARS Pharmaceuticals?

A short squeeze for ARS Pharmaceuticals occurs when it has a large amount of short interest and its stock appreciates in price. This forces short sellers to cover their short interest positions by buying actual shares of SPRY, which in turn drives the price of the stock up even further.

How often is ARS Pharmaceuticals' short interest reported?

Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including SPRY, twice per month. The most recent reporting period available is October, 15 2024.




This page (NASDAQ:SPRY) was last updated on 11/2/2024 by MarketBeat.com Staff
From Our Partners